Protecting the health of production personnel requires a robust approach to disease prevention, testing, and containment. Our team of doctors, scientists, and healthcare experts will partner with you to implement a robust disease management program, including screening, testing, and reporting through a single digital platform.
Deploy an end-to-end testing program, including screening, testing, and reporting through our secure, HIPPA-compliant online portal.
Review your current staffing plan, support hiring new staff as needed, and supervise your COVID-19 compliance team.
Complete a comprehensive assessment of your current processes, systems, and policies; and provide regular updates as new, credible information becomes available.
Provide case-by-case assessment of the potential business impact of scheduling decisions and protocol exceptions involving key personnel.
Recommend systems and practices, to minimize the risk of infection exposure, and provide ongoing compliance monitoring and personnel education.
Provide contact monitoring and tracing to contain the spread of infection when positive test results are reported, and communicate with employees who test positive.
Viral tests determine whether a person has an active COVID-19 infection. We use best-in-class assays that can detect the virus at very low levels in the body. Assays with low limits of detection are more likely to catch infected individuals than assays with higher limits.
Serology antibody tests determine whether a person has recently had a COVID-19 infection. Serologic tests look for the presence of antibodies in a blood sample. These tests should not be used to determine immunity status.
The CDC advises against using serology antibody tests to determine immunity. We are developing an antibody assay that will offer a more complete assessment of an individual’s immunity status.